Document Type : Original Article
- Onder G, Rezza G, Brusaferro S. Case‑fatality rate and
characteristics of patients dying in relation to COVID‑19 in Italy.
JAMA 2020;323:1775‑6.
2. Ruan S. Likelihood of survival of coronavirus disease 2019. Lancet
Infect Dis 2020;20:630‑1. - 3. Li Lq, Huang T, Wang Yq, Wang Zp, Liang Y, Huang Tb, et al.
COVID-19 patients’ clinical characteristics, discharge rate, and
fatality rate of meta-analysis. J Med Virol 2020;92:577‑83.
4. Gebhard C, Regitz‑Zagrosek V, Neuhauser HK, Morgan R,
Klein SL. Impact of sex and gender on COVID‑19 outcomes in
Europe. Biol Sex Differ 2020;11:1‑13.
5. Kirkcaldy RD, King BA, Brooks JT. COVID‑19 and postinfection
immunity: Limited evidence, many remaining questions. JAMA
2020;323:2245‑6.
6. Roy S. COVID‑19 reinfection: Myth or truth? SN Compr Clin Med
2020;2:710‑3.
7. Kashyap VK, Dhasmana A, Massey A, Kotnala S, Zafar N, Jaggi M,
et al. Smoking and COVID‑19: Adding fuel to the flame. Int J Mol
Sci 2020;21:6581.
8. Kaur G, Lungarella G, Rahman I. SARS‑CoV‑2 COVID‑19
susceptibility and lung inflammatory storm by smoking and
vaping. J Inflamm 2020;17:21.
)